Stephen A. Sherwin, Director of Biogen BIIB, has filed 0 purchases and 11 sales on the open market. Over the past 12 months that comes to a net sale of $4.1M. The latest trade was on 06/09.

SS

SS

Stephen A. Sherwin

Director

Company

Biogen BIIB

First filing

23/01/05

Trades

40 trades

Buys / sales

0 / 11

12-month net buying

−$4.1M

Last trade

06/09

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
Neurocrine BiosciencesNBIX	Open-market sale10b5-1 plan	06/05	06/09	25,000 sh5 trades	$165.32avg.	$4,132,990.2	−61.2%
BiogenBIIB	Open-market sale10b5-1 plan	25/03/07	25/03/10	8,760 sh	$150.02	$1,314,175.2	−43.6%
Neurocrine BiosciencesNBIX	Open-market sale10b5-1 plan	25/02/13	25/02/14	13,831 sh	$116.69	$1,613,939.39	−56.4%
Neurocrine BiosciencesNBIX	Open-market sale10b5-1 plan	24/05/29	24/05/30	40,000 sh2 trades	$133.46avg.	$5,338,550	−60.1%
Neurocrine BiosciencesNBIX	Open-market sale	23/01/03	23/01/05	30,000 sh2 trades	$118.86avg.	$3,565,800	−54.5%